ImmuCell Corporation (ICCC)
NASDAQ: ICCC · IEX Real-Time Price · USD
4.110
-0.050 (-1.20%)
Jul 22, 2024, 9:52 AM EDT - Market open
ImmuCell Employees
As of December 31, 2023, ImmuCell had 79 total employees, including 74 full-time and 5 part-time employees. The number of employees increased by 5 or 6.76% compared to the previous year.
Employees
79
Change (1Y)
5
Growth (1Y)
6.76%
Revenue / Employee
$269,402
Profits / Employee
-$49,334
Market Cap
32.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cutera | 430 |
Retractable Technologies | 151 |
Orgenesis | 146 |
IRIDEX | 111 |
ReWalk Robotics | 108 |
Immuneering | 68 |
Quince Therapeutics | 32 |
Longeveron | 24 |
ICCC News
- 12 days ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - GlobeNewsWire
- 6 weeks ago - ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® - GlobeNewsWire
- 6 weeks ago - ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 - GlobeNewsWire
- 2 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 - GlobeNewsWire
- 5 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 - GlobeNewsWire
- 5 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 - GlobeNewsWire